NIH-funded research Fellowship grant

How histone modifications affect gene regulation in cancer

Official title: Mechanisms of SAGA Regulation by Histone Crosstalk

Funded at Johns Hopkins University · NIH-10998572 · Data updated 2026-11-12

This study is looking at how a special protein complex called SAGA helps control gene activity in cancers linked to the c-myc gene, with the hope of finding new ways to treat these cancers that could help patients like you.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$76,756
NIH project number1F32GM156005-01
Project IDNIH-10998572 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with c-myc driven cancers who may benefit from targeted therapies.

Less likely to help

Patients with cancers not driven by c-myc or those with non-cancerous conditions may not receive benefits from this research.

What this research studies

This research investigates the role of the SAGA complex, which modifies histones to regulate gene transcription, particularly in the context of cancers driven by the c-myc gene. The project aims to understand how the SAGA complex's acetylation and deubiquitination activities interact with chromatin, potentially revealing new therapeutic targets. By using advanced techniques like cryo-electron microscopy, the research will explore the structural dynamics of the SAGA complex and its components. Patients may benefit from insights gained about how these processes can be manipulated for cancer treatment.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating c-myc driven cancers.

How similar studies have gone: Previous research has shown promising results in targeting histone modifications for cancer treatment, indicating that this approach has potential.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Fields, James Kemper — Johns Hopkins University
  • Study coordinator: Fields, James Kemper

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.